definiens: means all proprietary technical information, know - how and other IntellectualProperty which is owned or possessed by CELLSCRIPT that pertains to CELLSCRIPT ’s Kits or RNA ( e.g.,mRNA ) made using CELLSCRIPT ’s Kits, including but not limited to synthesis of uncapped RNA, cappedRNA and/or polyadenylated RNA, methods for controlling, increasing or modifying capping efficiency, synthesis and uses of RNA comprising [ * * ] in the in vitro - transcription product or incorporated as the capnucleotide using a capping enzyme, the assay or analysis of the percent of RNA capped or the identity or % of RNA with a particular cap structure ( e.g., cap0 versus cap1 ), methods for controlling lengths of poly(A ) tailand for assaying or analyzing poly(A ) tail lengths, methods for unbiased amplification of mRNA, methods forimproving delivery ( e.g., transfection ) of mRNA and/or expression of mRNA in mammalian cells, methods forreducing innate immunogenicity of in vitro - synthesized RNA, and methods or processes for in vitrotranscription, isolation, purification or storage of RNA . CELLSCRIPT Technology explicitly and withoutlimitation includes the information, experience, test results, know - how, instructions, standards, methods, CELLSCRIPT ’s SOPs, manufacturing processes, hazard assessments, quality control standards, formulae, specifications, storage data, samples, drawings, designs, analytical methods, cGMP processes pertaining toproduction, QC and QA of enzymes and Kits, validation reports of analytical methods and all other relevantinformation that is not publicly known relating to any of CELLSCRIPT ’s Kits or components or productsthereof other than the Argos Product that are supplied to Argos by CELLSCRIPT according to this Agreementand used by Argos for manufacture of Arcelis ® autologous vaccines